4D Molecular Therapeutics, Inc. (FDMT) stock
FDMTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/302% above fair value
$12.23+0.12 (+0.95%)
Close on Nov 13, 2026Market cap $882.76MP/E –Yield –
4D Molecular Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
4D Molecular Therapeutics's market cap was $717.23M on Nov 11, 2026, against $545.35M a year earlier. Over the last 5 years it ranged from $147.91M to $1.37B, with a median of $537.05M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $717.23M | +104.5% |
| 2025 | Dec 31, 2025 | $350.78M | +21.1% |
| 2024 | Dec 31, 2024 | $289.62M | -66.6% |
| 2023 | Dec 29, 2023 | $866.16M | +20.4% |
| 2022 | Dec 30, 2022 | $719.43M | +20.7% |
| 2021 | Dec 31, 2021 | $596.01M | +177.6% |
| 2020 | Dec 31, 2020 | $214.67M | – |
See a number that looks wrong?